Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

High concentration of lactic dehydrogenase in small volumes of ascites.

Izuishi K, Masaki T, Suzuki Y.

J Gastrointestin Liver Dis. 2010 Mar;19(1):105-6. No abstract available.

2.

New criteria for the differentiation between transudates and exudates.

Paramothayan NS, Barron J.

J Clin Pathol. 2002 Jan;55(1):69-71.

3.

Diagnosing ascitic etiology on a biochemical basis.

Bansal S, Kaur K, Bansal AK.

Hepatogastroenterology. 1998 Sep-Oct;45(23):1673-7.

PMID:
9840127
4.

Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.

Castaldo G, Oriani G, Cimino L, Topa M, Mostarda I, Castellano L, Del Vecchio-Blanco C, Budillon G, Salvatore F, Sacchetti L.

Clin Chem. 1994 Mar;40(3):478-83.

5.

Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.

Rana SV, Babu SG, Kocchar R.

Med Sci Monit. 2005 Mar;11(3):CR136-42.

PMID:
15735567
6.

[Diagnostic value of the determination of lactic dehydrogenase activity in ascitic fluid].

Bitelman B, Rafih DB, Silva Mde D, Polak M.

Rev Hosp Clin Fac Med Sao Paulo. 1980 Oct;35(5):239-42. Portuguese. No abstract available.

PMID:
7232986
7.

Serum/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites.

Akriviadis EA, Kapnias D, Hadjigavriel M, Mitsiou A, Goulis J.

Scand J Gastroenterol. 1996 Aug;31(8):814-7.

PMID:
8858753
8.

Peritoneal fluid lactate dehydrogenase in ovarian cancer.

Schneider D, Halperin R, Langer R, Bukovsky I, Herman A.

Gynecol Oncol. 1997 Sep;66(3):399-404.

PMID:
9299252
9.

Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.

Boyer TD, Kahn AM, Reynolds TB.

Arch Intern Med. 1978 Jul;138(7):1103-5.

PMID:
666469
10.

[Laboratory studies for the differential diagnosis of effusions].

Gambella O.

Quad Sclavo Diagn. 1973 Sep;9(3):791-800. Italian. No abstract available.

PMID:
4794506
11.

Utility of ascitic fluid analysis in patients with malignancy-related ascites.

Salerno F, Restelli B, Incerti P, Annoni G, Capozza L, Badalamenti S, Lampertico P, Mojana E, Moser P, Tommasini M.

Scand J Gastroenterol. 1990 Mar;25(3):251-6.

PMID:
1690913
12.

Usefulness of ascites/serum lactic dehydrogenase activity ratio in the initial approach to ascites.

Hurtado C, Chesta J.

Arq Gastroenterol. 1991 Apr-Jun;28(2):47-51.

PMID:
1843092
13.

[Biochemical markers of the tumor origin of ascites].

Romette J, di Costanzo-Dufetel J.

Pathol Biol (Paris). 1989 Jun;37(6):720-4. French.

PMID:
2780109
15.

Diagnostic paracentesis. A two-step approach.

Sartori M, Andorno S, Gambaro M, Leone F, Molinari GL, Pontiroli L, Aglietta M.

Ital J Gastroenterol. 1996 Feb-Mar;28(2):81-5.

PMID:
8781999
16.

Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.

Chen SJ, Wang SS, Lu CW, Chao Y, Lee FY, Lee SD, Wu SL, Cherng KL, Lo KJ.

J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):396-400.

PMID:
7948823
17.
19.

Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.

Prieto M, Gómez-Lechón MJ, Hoyos M, Castell JV, Carrasco D, Berenguer J.

Dig Dis Sci. 1988 Jul;33(7):833-8.

PMID:
2837370
20.

Nephrogenic ascites.

Craig R, Sparberg M, Ivanovich P, Rice L, Dordal E.

Arch Intern Med. 1974 Aug;134(2):276-9. No abstract available.

PMID:
4843195

Supplemental Content

Support Center